Clinical Trials in Celle, Germany
4 recruiting
Showing 1–5 of 5 trials
Recruiting
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Breast Neoplasms
Novartis Pharmaceuticals3,250 enrolled267 locationsNCT06830720
Recruiting
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
Multiple Sclerosis
Hoffmann-La Roche842 enrolled74 locationsNCT06780150
Recruiting
NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
Non-squamous Metastatic Non-Small-Cell Lung Carcinoma
AstraZeneca600 enrolled21 locationsNCT06494540
Recruiting
Phase 2Phase 3
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Hairy Cell Leukemia
University of Giessen210 enrolled76 locationsNCT02131753
Recruiting
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Metastatic Colorectal Carcinoma
Pierre Fabre Pharma GmbH500 enrolled70 locationsNCT04673955